medigraphic.com
ISSN 1405-8871 (Impreso)

2020, Número 3

<< Anterior Siguiente >>

Aten Fam 2020; 27 (3)


Síndrome de intestino irritable: un enfoque integral

Mendoza LG, Becerra TEC

Idioma: Español
Referencias bibliográficas: 33
Paginas: 150-154
Archivo PDF: 115.89 Kb.


RESUMEN

El síndrome de intestino irritable (sii) es una enfermedad crónica que afecta la función gastrointestinal y requiere una demanda importante de atención médica; su incidencia aumenta dependiendo de los estilos de vida y otras comorbilidades. Actualmente el enfoque terapéutico se debe hacer de forma integral llevando a cabo un adecuado seguimiento y tratamiento. El objetivo de esta revisión es dar a conocer los factores de riesgo, la sintomatología y el tratamiento utilizado para este síndrome, con el propósito de fortalecer su abordaje multidisciplinario y mejorar la calidad de vida de los pacientes.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Zhou S, Liu X, Wang X, Pharmacological and non-pharmacological treatments for irritable bowel syndrome: Protocol for a systematic review and network meta-analises. Medicine (Baltimore). 2019;98(30):e16446.

  2. Ghiasi F, Amra B, Sebghatollahi V, Azimian F. Association of irritable bowel syndrome and sleep apnea in patients referred to sleep laboratory. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences. 2017;22.

  3. Qin D, Xue B, Chen M, Pharmacological treatments for patients with bowel syndrome: An umbrella review of systematic reviews and metaanalises. Medicine. 2019;98(32).

  4. Mei S, Wen YL, Hou HB, Effectiveness of vitamin D for irritable bowel syndrome: A protocol for a systematic review of randomized controlled trial. Medicine. 2019;98(9):e14723.

  5. Lopes S, Miszputen JS, Sachs A, Evaluation of carbohydrate and fiber consumption in patients with irritable bowel syndrome in outpatient treatment. Arq. Gastroenterol. 2019;56(1):3-9.

  6. Pittayanon R, Lau J, Yuan Y, Gut Microbiota in Patients With Irritable Bowel Syndrome- A Systematic Review. Gastroenterology. 2019;157:97- 108.

  7. Tack J, Stanghellini V, Mearin F. Economic burden of moderate to severe irritable bowel syndrome with constipation in six European counties. BMC Gastroenterology. 2019;19(69):1-13.

  8. Grupo de trabajo de la guía de práctica clínica sobre el síndrome del intestino irritable. Manejo del paciente con síndrome del intestino irritable. Barcelona: Asociación Española de Gastroenterología, Sociedad Española de Familia y Comunitaria y Centro Cochrane Iberoamericano, 2005.

  9. Goldenberg JZ, Acero A, Day A. Naturopathic approaches to irritable bowel syndrome: protocol for a prospective observational study in academic teaching clinics. Integr Med Res. 2018;7(3):279- 286.

  10. Ghiasi F, Amra B, Sebghatollahi V. Association of irritable bowel syndrome and sleep apnea in patient referred to sleep laboratory. J. Res. Med. Sci. 2017;22:72.

  11. Larussa T, Rossi M, Suraci E. Use of Complementary and Alternative Medicine by Patients with Irritable Bowel Syndrome According to the Roma IV Criteria: A Single-Center Italian Survey. Medicina (Kaunas). 2019;55(2):46.

  12. O’ Mahony SM, Clarke G, Dinan TG. Irritable Bowel Syndrome and Stress-Related Psychiatric Co-morbidities: Focus on Early Life Stress. Handb Exp Pharmacol. 2017;239:246.

  13. Sehonou J, Dodo LR. Profil clinique et facteurs associés au syndrome de I’ntestin irritable chez les etudiants en medicine á Cotonou, Bénin. Pan Afr Med J. 2018;19(31):123.

  14. Williams CE, Williams EA, Corfe BM. Vitamin D status in irritable bowel syndrome and the im- pact of supplementation on symptoms: what do we know and what do we need to know. Eur J Clin Nutr. 2018;72(10):1358-63.

  15. Canicoba M, Nastasi V. La dieta reducida en FODMAP: ventajas y controversias. Nutr Clin Med. 2016;10(1):20-39.

  16. Barbalho SM, Goulart RA, Araújo AC. Irritable Bowel Syndrome: a review of the general aspects and the potential role of vitamin D. Expert Review of Gastroenterology and Hepatology. 2019;13(4):345-59.

  17. Xu D, Chen VL, Steiner CA. Efficacy of fecal Microbiota Transplantation in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis. J Gastroenterol. 2019;114(7):1043-50.

  18. Tu Q, Heitkemper MM, Jarret ME. Sleep Disturbances in Irritable Bowel Syndrome: a systematic review. WILEY NGM. 2016.

  19. Sadeghian M, Sadeghi O, Keshteli AH, Physical activity in relation to irritable bowel syndrome among Iranian adults. PLoS One. 2018;13(10).

  20. Domingo JJ. Los nuevos criterios de Roma (IV) de los trastornos funcionales digestivos en la práctica clínica. Med Clin. 2017;148(10):464-468.

  21. Simrén M, Tomblom H, Palsson O. Cumulative Effects of Psychologic Distress, Visceral Hypersensitivity, and Abnormal Transit on Patient-reported Outcomes in Irritable Bowel Syndrome. Gastroenterology. 2019;157(2):391-402.

  22. Diagnóstico y Tratamiento del Intestino Irritable en el Adulto. México: Secretaría de Salud; 2015. [Internet]. [Citado 2019 Sep 15] Disponible en: http://www.cenetec.salud.gob.mx/interior/catalogoMaestroGPC. html

  23. Laird KT, Tanner E, Rusell A. Comparative efficacy of psychological therapies for improving mental health and daily functioning in irritable bowel syndrome: A systematic review and meta-analysis. Clinical Psychology Review. 2017;51:142-152.

  24. Casellas F. Burgos R. Marcos A. Consensus documento on exclusión diets in irritable bowel sindrome (IBS) Nutr Hosp. 2018:35(6):1450-66.

  25. Heavey E, Eileen D. Limitig FODMAP consumption for patients with IBS. Nursing. 2018;48(11):54-7.

  26. Frieling T, Heise J, Krumen B, Hundorf C. Tolerability the FODMAP reduced diet in irritable bowel syndrome efficacy-adherence and body weight course. Gastroenterol. 2019;57(6):740-44.

  27. Mari A, Hosadurg D, Martin L. Adherence with a low FODMAP diet in irritable bowel syndrome: are eating disorders the missing link?. Eur J Gastroenterol Hepatol. 2019;31(2):178-82.

  28. Zhang FM, Li S, Ding L. Effectiveness of mesalazine to treat irritable bowel syndrome. Medicine. 2019;98:28.

  29. Alammar N, Wang L, Saberi B. The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis of the pooled clinical data. BMC Complement Altern Med. 2019;19(1):21. doi: 10.1186/s12906-018-2409-0.

  30. Liang D, Longgui N, Guoqiang X. Efficacy of different probiotic protocols in irritable bowel syndrome A network meta-analysis. Medicine. 2019;98:27.

  31. Wilson B, Rossi M, Dimidi E. Prebiotics in irritable bowel syndrome and other functional bowel disorders in adults: a systematic review and meta-analysis of randomized controlled trials. The American Journal of Clinical Nutrition. 2019;109(4):1098-11.

  32. Eales J, Gibson P, Whorwell P. Systematic review and meta-analysis: the effects of fermented milk with Bifidobacterium lactis CNCM 1-2494 and lactic acid bacteria on gastrointestinal discomfort in the general adult population. Therap Adv Gastroenterol. 2017;10(1):74-88.

  33. Munjal A. Dedania B. Cash B. Update on Pharmacotherapy for Irritable Bowel Syndrome. Curr Gastroenterol Rep. 2019;21(6):25.




2020     |     www.medigraphic.com